Details for Patent: 3,746,697
Summary for Patent: 3,746,697
| Title: | Tripeptide having the activity of the thyrotropin releasing hormone |
| Abstract: | A SYTHETIC PRODUCT (PYRO) GLUTAMYL-HISTIDYL-PROLINE AMIDE, HAVING THE SPECIFIC AND UNIQUE ACTIVITIES OF THE THYROTROPIN RELEASING HORMONE OF THE HYPOTHALAMUS GLAND, IS OBTAINED FROM THE TRIPEPTIDE, A-GLUTAMYL-HISTIDYLPROLINE. THE TRIPEPTIDE CAN BE CONVERTED TO THE AMIDE FORM BY REACTING THE DIMETHYLESTER WITH METHANOL AND AMMONIA TO OBTAIN THE (PYRO) GLUTAMYL-HISTIDYL-PROLINE AMIDE. |
| Inventor(s): | K Folkers, F Enzmann |
| Assignee: | Individual |
| Application Number: | US00859559A |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 3,746,697
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 3,746,697
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018870 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
